Clinical Trial Update: A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head) [Phase 3]

View source ↗

Summary

Phase 3 study evaluating combinations of anti-LAG-3 and anti-PD-1 antibodies in adults with advanced or metastatic melanoma; the trial is currently recruiting (…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Anti-LAG-3 antibody
• Anti-PD-1 antibody

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Melanoma | Phase 3 | Status: RECRUITING